What Researchers Did
Researchers presented a case report detailing a patient with cutaneous B-cell lymphoma who experienced rapid disease progression during hyperbaric oxygen therapy.
What They Found
They found that a patient with cutaneous B-cell lymphoma and non-healing ulcerations, who began hyperbaric oxygen (HBO₂) therapy, experienced worsening wounds shortly after treatment initiation. Subsequent biopsies confirmed rapid progression to cutaneous large B-cell lymphoma, leading to HBO₂ discontinuation and aggressive chemotherapy.
Canadian Relevance
This specific case report has no direct Canadian connection.
Study Limitations
As a single case report, these findings may not be generalizable to all patients with cutaneous B-cell lymphoma undergoing hyperbaric oxygen therapy.